Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings
Angela Collarino, Elizabeth J. de Koster, Renato A. Valdés Olmos, Lioe Fee de Geus-Oei, Lenka M. Pereira Arias-Bouda* (Corresponding Author)
Dive into the research topics of 'Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings'. Together they form a unique fingerprint.